Treatment of acute C hepatitis in intravenous drug users [2]

Journal of Hepatology

Volumn 43, Issue 1, 2005, Pages 186-187

  Bargiacchi, Olivia ^a   Audagnotto, Sabrina ^a   Garazzino, Silvia ^a   De Rosa, Francesco G ^a  

^a AMEDEO DI SAVOIA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2B;

ACUTE HEPATITIS; CLINICAL FEATURE; COMORBIDITY; DEPRESSION; DOCTOR PATIENT RELATION; DRUG TOLERABILITY; FOLLOW UP; GENOTYPE; HEPATITIS C; HUMAN; INFORMED CONSENT; INTRAVENOUS DRUG ABUSE; LETTER; MEDICAL DOCUMENTATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIDE EFFECT; VIOLENCE;

ACUTE DISEASE; ANTIVIRAL AGENTS; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 20444382348     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.03.010     Document Type: Letter

References (3)

1. B. Broers, B. Helbling, A. François, P. Schmid, C. Chuard, and A. Hadengue for the Swiss Association for the Study of the Liver (SASL 18). Barriers to interferon-α therapy are higher in intravenous drug users than in other with acute hepatitis C J Hepatol 42 2005 323 328
2. E. Jaeckel, M. Cornberg, H. Wedemeyer, T. Santantonio, J. Mayer, and M. Zankel Treatment of acute hepatitis C with interferon alfa-2b N Engl J Med 345 2001 1452 1457
3. M. Shaefer, A. Heinz, and M. Backmund Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules? Addiction 99 2004 1167 1175